The Neurofibromatosis Drugs Market is also influenced by growing research into the tumor microenvironment and cellular signaling. A deeper understanding of these mechanisms may create opportunities for therapies designed to control tumor development and progression. The global Neurofibromatosis Drugs Market was valued at US$ 3.45 Billion in 2025 and is expected to reach US$ 12.34 Billion by...